US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Phase 2 Clinical Trial

Recent news which mentions Phase 2 Clinical Trial

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Tickers NEWS TYPTF
Tags Phase 2 Clinical Trial Health Care Benzinga
From Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
Tickers ATAI CMPS
Tags ATAI Ketamine/Assisted Therapy Markets
From Benzinga
Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial
Tickers KONEF NMLSF
Tags KGK Science Inc/ Benzinga Phase 2 Clinical Trial
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Tickers MKGAF MKKGY NKTR PFE
Tags Phase 2 Clinical Trial Health Care Briefs
From Benzinga
Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
Tickers CLRB
Tags Phase 2 Clinical Trial Briefs Health Care
From Benzinga